Voyager Genetics was created by Christopher Leavitt in 2024 after he journeyed from California to Portugal on a quest to bring medical patients in the European Union truly exceptional cannabis products. We are dedicated to making cannabis products that have the best outcomes for patients with as much scientific rigor as possible, partnering with exceptional growers and manufacturers to bring high quality, safety, and efficacy medicine to patients.

With an focus on curated selections of clone-only varieties, commercial medical cultivators can avoid the instability of the “hype” market and target varieties that have strong agronomic traits, compliant sources, validated chemotypes, and the artistry of delicious aromas and stunning bag appeal.

We work hard to create a small number of products that truly shine.